If you’re scaling terpenes across borders, compliance is no longer optional. It’s the difference between selling in a market and getting shut down.
This guide covers terpene regulations in four major markets: US, EU, Canada, and Australia. The rules vary significantly, and they’re constantly evolving.
United States: Complex State-by-State
The US doesn’t have a single terpene rule. Instead, you have federal regulations plus 50 state regulations, and they conflict.
Federal Level: Botanical terpenes are legal at the federal level. They’re classified as food additives and flavoring agents under FDA purview. Cannabis-derived terpenes (CDT) are prohibited at the federal level. Any terpene extracted from cannabis is regulated as a Schedule I substance under the DEA. This applies even in legal states.
State Level (Legal Cannabis States): In states where cannabis is legal, the situation is nuanced. California: CDT is legal if extracted from legal cannabis. Requires state-licensed extraction facility, track-and-trace documentation (Metrc system), and state testing. Botanical is unrestricted.
Colorado: CDT is legal from licensed sources. Requires approval from Colorado Marijuana Enforcement Division, track-and-trace, and testing.
Oregon: CDT is legal but with restrictions on use. Can’t be exported out of state (even to other legal states). Botanical is unrestricted.
Washington: CDT is legal from licensed producers. Track-and-trace required. Botanical unrestricted.
Real-world implication: A vape brand in California can legally sell CDT cartridges in California but can’t ship them to Oregon. They’d need separate botanical inventory for Oregon.
European Union: Strict, Federalized
The EU has one harmonized regulatory system across member states. It’s stricter than the US and more consistent.
Botanical Terpenes: Legal. Terpenes from botanical sources are regulated as flavoring agents under EC Regulation 1169/2011 and EC Regulation 2015/2283 (novel foods regulation).
What’s required:
- EFSA (European Food Safety Authority) approval if the plant is non-traditional in Europe
- Contaminant testing (pesticides, heavy metals, microbial)
- GC-MS verification of terpene identity
- Labeling requirements (ingredient declaration, allergen labeling if applicable)
- Manufacturer must have food safety certification (ISO 22000 or HACCP)
Lead time: EFSA approval for novel plants can take 12-24 months. If using traditional plants (pine, lemon, lavender), approval is faster (3-6 months).
Cannabis-Derived Terpenes: Prohibited in most EU states. Cannabis is federally restricted. Even if extracted in countries like Netherlands where cannabis is semi-legal, cross-border transport is problematic.
Canada: Progressive, Cannabis-Integrated
Canada has legalized cannabis and, as a result, has actual CDT regulations (unlike the US).
Botanical Terpenes: Legal. Regulated as food additives under the Food and Drugs Act.
What’s required:
- Health Canada approval (if using non-traditional plants; traditional plant list exists)
- Contaminant testing (pesticides, heavy metals, microbial)
- GC-MS verification
- Manufacturer must have food safety certification
- Labeling in English and French
Lead time: 2-6 months for approval depending on plant novelty.
Cannabis-Derived Terpenes: Legal, but strictly regulated for cannabis products only. CDT extracted from cannabis can be used in licensed cannabis products (under Health Canada oversight). Only by licensed producers. Only for consumption within Canada (not export).
Real-world: A Canadian vape brand can use CDT in cartridges sold in Canada but can’t export them (even to the US, even to California).
Australia: Restrictive, Evolving
Australia has strict import and export controls. Terpenes are regulated differently depending on source and intended use.
Botanical Terpenes: Legal, but restricted. Imported botanical terpenes must be pre-approved by TGA if marketed for health purposes, pre-approved by FSANZ if marketed as food ingredients, and clear Australian customs (biosecurity requirements for plant-derived materials).
Cannabis-Derived Terpenes: Illegal for consumer products. Cannabis is Schedule 8 (prohibited for most purposes). Medical cannabis was legalized in 2016 but is strictly controlled. CDT is not approved for any consumer product. Full prohibition.
Compliance Checklist
Before selling terpenes in a new market:
- Confirm botanical vs CDT legality in the market
- Identify the regulatory authority (FDA/state in US, EFSA in EU, Health Canada, TGA/FSANZ in Australia)
- Obtain GC-MS testing from an accredited lab in that market
- Verify manufacturer has local GMP certification
- Check if health claims trigger additional approval (they usually do)
- Budget €5k-€50k+ and 3-12 months for regulatory approval
- Maintain documentation for 3-7 years depending on market
- Plan for labeling translation and compliance (language requirements vary)
Most brands don’t realize compliance is a competitive advantage. Brands that know regulations win distribution with sophisticated buyers.
